Creon dosing information for chronic pancreatitis and pancreatectomy approved - ONA

Links shared publicly online about this topic.

  • 1,195
    total visits

Creon dosing information for chronic pancreatitis and pancreatectomy approved - ONA

oncologynurseadvisor.com

The supplemental New Drug Application (sNDA) for Creon (pancrelipase delayed-release capsules, from Solvay) has been approved by the FDA to include dosing guidance in the prescribing information specific to patients with exocrine pancreatic insufficiency (EPI) due to chronic pancreatitis (CP) or pancreatectomy.

View full resource at oncologynurseadvisor.com

Tags: Pancreatic Disease, Drug, FDA, Solvay

  • Share

Most Recently Shared on May 3, 2010 at 8:48 pm By:

ONAcom OncologyNurseAdvisor

Creon dosing information for chronic pancreatitis and pancreatectomy approved http://goo.gl/fb/Z7HVV

2 years ago...

Abbott Receives FDA Approval For CREON(R) To Include Dosing Information For Patients With Chronic Pancreatitis And Pancreatectomy

medicalnewstoday.com — “Abbott today announced that the U.S. Food and Drug Administration (FDA) approved the supplemental New Drug Application (sNDA) for CREON® (pancrelipase) Delayed-Release Capsules that now includView full resource at medicalnewstoday.com

  • View Related
  • Share

Most Recently Shared on May 5, 2010 at 12:19 pm By:

mnt_drugapprov MNT Drug Approvals Health News

Abbott Receives FDA Approval For CREON(R) To Include Dosing Information For Patients With Chronic Pancreatitis And Pan... http://mnt.to/3C8g

2 years ago...

Creon dosing information for chronic pancreatitis and pancreatectomy approved - MPR

empr.com — “The supplemental New Drug Application (sNDA) for Creon (pancrelipase delayed-release capsules, from Solvay) has been approved by the FDA to include dosing guidance in the prescribing information specific to patients with exocrine pancreatic insufficiency (EPI) due to chronic pancreatitis (CP) or pancreatectomy.View full resource at empr.com

  • View Related
  • Share

Most Recently Shared on May 3, 2010 at 9:09 pm By:

eMPR MPR Medical Publisher

MPR News: Creon dosing information for chronic pancreatitis and pancreatectomy approved: The supplemental New Drug... http://bit.ly/ajHsGR

2 years ago...

Abbott Receives FDA Approval for CREON to Include Dosing Information for Patients with Chronic Pancreatitis and Pancreatectomy: May 3, 2010

abbott.com — “Abbott Receives FDA Approval for CREON to Include Dosing Information for Patients with Chronic Pancreatitis and PancreatectomyView full resource at abbott.com

  • View Related
  • Share

Most Recently Shared on May 3, 2010 at 1:42 pm By:

eyeonfda eyeonfda Pharma and Health Lawyer

Abbott Gets FDA Approval 4 CREON® to Incl Dosing Info for Patients w/Chronic Pancreatitis & Pancreatectomy - http://ow.ly/1Gepa

2 years ago...

Advertisement